Humans In Space

Humans In Space Insights

Investing in the Space Healthcare Convergence

2025-12-29
<figure class='media'><oembed url='https://www.youtube.com/embed/YYnq70LsX5Q?si=QJsWyFWSCdtSzXON'></oembed></figure><h3> </h3><p><span class='text-huge'><strong>Jackson Labovitz on Market Signals, Ecosystem Design, and the Next Wave of Space Innovation</strong></span></p><h4> </h4><p>As launch costs decline and commercial access to orbit expands, the space sector is entering a phase in which scientific capability and investment logic increasingly align. </p><p>For <strong>Jackson Labovitz</strong>, Senior Associate at <strong>Aurelia Foundry</strong>, this transition is defined not by novelty, but by the accelerating feasibility of space-enabled technologies that can generate meaningful outcomes on Earth.</p><p>Labovitz served as a judge for the <strong>Humans In Space (HIS) Challenge</strong> in consecutive years, citing the program’s ability to convene high-quality innovators and translate early exposure into concrete support.</p><blockquote><p><strong>“We had a great time meeting the cohort last year… a lot of really strong companies and researchers came out of that cohort. And we actually invested in several of those companies.”</strong><br><strong>— </strong><i><strong>Jackson Labovitz</strong></i></p></blockquote><p> </p><p>For Aurelia, the HIS Challenge functions as more than a visibility platform—it is a structured pathway to identify teams and solutions positioned for both technical execution and commercial scale .</p><p> </p><p><span class='text-big'><strong>Why Humans In Space Matters to Investors </strong></span></p><p>Labovitz highlights the value of the HIS ecosystem in addressing a persistent constraint in space investment: fragmented expertise across science, industry, and capital. By convening investors alongside domain specialists and industry leadership, HIS enables more informed interpretation of market signals and earlier validation of real-world demand.</p><blockquote><p><strong>“The Humans In Space Challenge brings together unique partnership—Boryung, industry experts, and investors… We are able to leverage each other’s expertise… and support the cohort in a more holistic way.”</strong></p></blockquote><p> </p><p>This integrated model strengthens decision-making for investors and improves the probability that promising concepts receive the operational guidance and strategic partnerships necessary to mature beyond experimentation.</p><p> </p><p><span class='text-big'><strong>Investment Criteria in Space and Healthcare</strong></span></p><p>When assessing opportunities in the space sector—particularly where healthcare, exploration, and infrastructure intersect—Labovitz emphasizes three primary considerations:</p><p><strong>1. Team quality and execution capacity</strong><br>At early stages, technical ambition must be matched by leadership capable of navigating long development cycles and complex validation environments.</p><p><strong>2. Clear Earth-based market relevance</strong><br>Space is increasingly viewed as an enabling environment, not the end market. The strongest opportunities are those where research or production in space unlocks value that is scalable on Earth.</p><blockquote><p><strong>“Being able to evaluate a large Earth-based market—where what’s done in space can come back and have a huge impact on Earth—is super important.”</strong></p></blockquote><p> </p><p><strong>3. Credible return narrative</strong><br>For investors and limited partners alike, the pathway to returns must be legible. Demonstrating how space-enabled outcomes translate into measurable value on Earth is essential to underwriting investment theses.</p><p> </p><p><span class='text-big'><strong>The Emerging Opportunity Landscape</strong></span></p><p>Labovitz identifies declining launch costs as a catalyst for “secondary innovation”—a rapid expansion of viable business use cases enabled by increased access to orbital environments.</p><blockquote><p><strong>“We’re seeing a huge wave of innovation… There’s an exponential jump in business use cases that are now becoming available.”</strong></p></blockquote><p> </p><p>He points to life sciences and advanced manufacturing as particularly active domains, including pharmaceuticals, drug discovery, and other forms of space-enabled production.</p><blockquote><p><strong>“Whether it’s in pharmaceuticals and drug discovery or other manufacturing, there’s a lot that can be done.”</strong></p></blockquote><p> </p><p> </p><p><span class='text-big'><strong>The Positioning for the Next Phase</strong></span></p><p>For investors evaluating the sector’s direction, Labovitz’s position is unequivocal: the market is moving quickly, and early participation matters.</p><blockquote><p><strong>“Investors should really jump on board… There’s a lot happening in space.”</strong></p></blockquote><p> </p><p>Through Humans In Space, Boryung continues to convene a cross-disciplinary platform that reduces barriers to entry, strengthens collaboration, and accelerates the translation of space research into practical value on Earth—an approach consistent with the broader narrative of the Multi-Planetary Human Life Series.</p>
list